CureVac B.V. (CVAC)

[XenaLives]

CureVac is truly a one-stop shop for mRNA therapeutics, encompassing every step along the R&D journey, from discovery to production. Our high standards for discovery and production have led to high returns—we currently have 693 granted patents.

At CureVac, we describe our production philosophy as “biopharma meets IT.” Much like a programmer will write a code that carries instructions to a computer, during our R&D process, we use mRNA sequences to “write” a new “code” that will be translated by the body to the corresponding protein. This process means we have the possibility to use the same, standardized process to produce all of our mRNA therapeutics.

https://www.curevac.com/en/technology/production/